Belvedere Trading’s Evolent Health EVH Stock Holding History

Belvedere Trading’s Portfolio EVH Stock Details EVH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-50,094	Closed	-$1.52M	–	499
2021 Q3	$1.52M	Buy	+50,094	New	+$1.2M	0.04%	34

Other funds holding EVH

Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

Belvedere Trading's EVH Position: Q4 2021 in Review

Belvedere Trading sold out of Evolent Health (EVH) in Q4 2021, closing a stake of 50,094 shares — an estimated $1.52M sold.

Belvedere Trading first reported a position in EVH in Q3 2021 and held it in 1 quarter. The position peaked at $1.52M in Q3 2021. 207 funds tracked by Wall St. Rank hold EVH as of Q4 2021.

Belvedere Trading reported no remaining Evolent Health position as of Q4 2021 after selling out during the quarter.
Belvedere Trading sold 50,094 Evolent Health shares in Q4 2021, an estimated $1.52M.
Belvedere Trading first reported a position in Evolent Health in Q3 2021 and held it in 1 quarter.
Belvedere Trading's Evolent Health position peaked at $1.52M in Q3 2021.
207 funds tracked by Wall St. Rank held Evolent Health as of Q4 2021.

Based on Belvedere Trading's 13F filing for Q4 2021, filed 25 Jan 2022.